Fox Chase Cancer Center Foundation
- Assets
- $52.2m
- Revenue
- $5.2m
- Investments
- $0.0
- Employees
- 0
- Location
- Philadelphia, PA
- Founding
- 05/1975
- Data as of
- 06/2022
- EIN
- 23-2003072
Organization Overview
Fox Chase Cancer Center Foundation is located in Philadelphia, PA. The organization was established in 1975. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Fox Chase Cancer Center Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Fox Chase Cancer Center Foundation generated $5.2m in total revenue. This represents relatively stable growth, over the past 3 years the organization has increased revenue by an average of 0.2% each year. All expenses for the organization totaled $3.1m during the year ending 06/2022. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO PREVAIL OVER CANCER, MARSHALING HEART AND MIND IN BOLD SCIENTIFIC DISCOVERY, PIONEERING PREVENTION AND COMPASSIONATE CARE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE FOUNDATION HOLDS AND INVESTS PERMANENT ENDOWMENT FUNDS FOR THE BENEFIT OF, AND MAKES ANNUAL GRANTS TO, THE AMERICAN ONCOLOGIC HOSPITAL (D/B/A HOSPITAL OF THE FOX CHASE CANCER CENTER) AND ITS AFFILIATE, THE INSTITUTE FOR CANCER RESEARCH.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Dr Donald Morel Director/chairman | OfficerTrustee | 1 | $0 |
Louis Della Penna Director/vice Chairman | OfficerTrustee | 1 | $0 |
Dr Robert Uzzo President (from 11/24/21) | OfficerTrustee | 1 | $0 |
William Federici Director | Trustee | 1 | $0 |
Edward Glickman Director | Trustee | 1 | $0 |
Julia Goplerud Director | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
| Total Program Service Revenue | $0 |
| Investment income | $997,832 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $4,204,523 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $5,202,355 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $3,047,156 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $58,645 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $0 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $3,105,801 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $27,778 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $52,178,842 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $52,206,620 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
| Net assets without donor restrictions | $0 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $52,206,620 |
| Total liabilities and net assets/fund balances | $52,206,620 |
Grants Awarded
Over the last fiscal year, Fox Chase Cancer Center Foundation has awarded $3,047,156 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
THE INSTITUTE FOR CANCER RESEARCH PURPOSE: Annual Spend Rule Allocation of Permanently Restricted Endowment | $2,702,125 |
THE AMERICAN ONCOLOGIC HOSPITAL PURPOSE: Annual Spend Rule Allocation of Permanently Restricted Endowment | $345,031 |